Literature DB >> 6623009

Circulating immune complexes in rheumatoid arthritis with extra-articular manifestations.

H Jans, P Halberg, I Lorenzen.   

Abstract

Circulating immune complexes (CIC) and complement C4, C3 and CH50 levels in serum were monitored during 6-30 months in 10 patients with rheumatoid arthritis and extra-articular manifestations (EM). A total of 58 observations were made, 17 at times when new EM emerged, 41 at times when the patients were in a steady state. CIC were demonstrated by two methods, viz. a complement consumption test (CCT) and a polyethyleneglycol (PEG) precipitation assay. The precipitates were analysed for their content of IgG, IgM and IgA. The CCT titre decreased significantly at the time of a new EM, whereas PEG precipitates were found most often at this time. Two types of precipitate could be demonstrated. One consisted of IgG only, which was found most often when the patients were in a steady state. The other one was composed of IgG and other immunoglobulins, most often IgA. The latter type was found most often at the time when the patients developed new EM. Subnormal serum complement levels were demonstrated frequently. The level of C4 was significantly lower at the time of a new EM, compared with the level of patients with RA but without EM. The decrease in anticomplementary effect and the signs of complement activation suggest that the qualitative and quantitative changes in CIC observed at the time of new EM were the cause rather than the consequence of the clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6623009     DOI: 10.3109/03009748309098536

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  6 in total

1.  Rheumatoid vasculitis: early presentation of rheumatoid arthritis.

Authors:  Yasir Abdulqader; Muhsen Al-Ani; Konstantinos Parperis
Journal:  BMJ Case Rep       Date:  2016-11-08

2.  Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Authors:  K Hørslev-Petersen; K D Bentsen; A Engström-Laurent; P Junker; P Halberg; I Lorenzen
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

3.  Increased cellularity and expression of adhesion molecules in muscle biopsy specimens from patients with rheumatoid arthritis with clinical suspicion of vasculitis, but negative routine histology.

Authors:  P C Verschueren; A E Voskuyl; T J Smeets; K H Zwinderman; F C Breedveld; P P Tak
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

4.  Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis.

Authors:  M L Westedt; M R Daha; W M Baldwin; T Stijnen; A Cats
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

5.  Immunological comparison of patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Korpela; J Mustonen; H Helin; A Pasternack
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

6.  IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus.

Authors:  C E Siegert; M R Daha; S Lobatto; E A van der Voort; F C Breedveld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.